Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Looking ahead

No hearings or votes scheduled.

History

1. 2026
   1. Mar 23Failed to pass pursuant to Senate Joint Resolution 1Latest
   2. Feb 13Representative Bare added as a coauthor
   3. Feb 12Representative Franklin added as a coauthor
   4. Feb 11Representatives Stubbs and Hysell added as coauthors
   5. Feb 11Public hearing held
   6. Feb 10Assembly Amendment 1 offered by Representative NovakMinor
2. 2025
   1. Nov 13Representative Andraca added as a coauthor
   2. Oct 8Senator Carpenter added as a cosponsor
   3. Oct 3Representative Cruz added as a coauthor
   4. Sep 16Representative Donovan added as a coauthor
   5. Sep 11Representative Sinicki added as a coauthor
   6. Sep 9Representative J. Jacobson added as a coauthor
   7. Aug 28Representative Palmeri added as a coauthor
   8. Jun 18Fiscal estimate receivedMinor
   9. Jun 11Representative Emerson added as a coauthor
   10. Jun 5Representative Udell added as a coauthor
   11. May 29Senator Smith added as a cosponsor
   12. May 22Representative Ortiz-Velez added as a coauthor
   13. Apr 23Fiscal estimate receivedMinor
   14. Apr 11Representative Rivera-Wagner added as a coauthor
   15. Apr 9Read first time and referred to Committee on Health, Aging and Long-Term CareMinor
   16. Apr 9Introduced by Representatives Novak, Tranel, Allen, Armstrong, Brooks, Callahan, Fitzgerald, B. Jacobson, Joers, Kirsch, Kitchens, Knodl, Kreibich, McCarville, Miresse, Mursau, O'Connor, Sortwell, Tittl, Wichgers and Tucker; cosponsored by Senators Felzkowski, Marklein, Cabral-Guevara, Dassler-Alfheim, Drake, Habush Sinykin, L. Johnson, Keyeski, Larson, Nass, Pfaff, Quinn, Ratcliff, Roys, Spreitzer, Wanggaard, Wimberger and JamesIntroduced